Literature DB >> 19116751

Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.

Ryash Vather1, Tarik Sammour, Arman Kahokehr, Andrew B Connolly, Andrew G Hill.   

Abstract

BACKGROUND: The most important prognostic factor in colonic cancer is the presence or absence of regional lymph nodes metastases. The aim of this study was to evaluate the relationship between 5-year mortality in the New Zealand population, and the number of nodes examined in Stage II and III colon cancers.
METHODS: New Zealand Cancer Registry data were retrieved for patients with colonic cancer from January 1995 to July 2003. Patients with incomplete entries, Stage I tumors, and distant metastases were excluded from analysis. Univariate and Cox regression models were used with 5-year mortality as the primary endpoint.
RESULTS: The study identified 4309 patients. Younger age, female gender, Pacific Island descent, and right-sided tumors were associated with significantly higher lymph node retrieval. Cox regression analysis showed that the number of nodes examined was a significant predictor of 5-year mortality when age, sex, ethnicity, and site were controlled for. Five-year survival consistently improved between nodal strata until the 16-node mark, above which survival advantage was minimal. For Stage III cancers, a higher lymph node ratio was associated with a significant increase in mortality.
CONCLUSIONS: Increased rates of nodal examination are associated with a significantly lower 5-year mortality for Stage II and III colonic cancer, but this survival advantage appears to be minimal after the 16-node mark. The lymph node ratio has been validated as a powerful predictor of survival in Stage III cancer. Our results support the current practice of harvesting and examining as many nodes as possible during attempted curative resection.

Entities:  

Mesh:

Year:  2008        PMID: 19116751     DOI: 10.1245/s10434-008-0265-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  66 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Evaluation of lymph nodes in patients with colon cancer undergoing colon resection: a population-based study.

Authors:  Yun-Jau Chang; Yao-Jen Chang; Li-Ju Chen; Kuo-Piao Chung; Mei-Shu Lai
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

3.  Dukes C colorectal cancer: is the metastatic lymph node ratio important?

Authors:  Matthew Thomas; Somita Biswas; Faheez Mohamed; Kandiah Chandrakumaran; Madan Jha; Robert Wilson
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

4.  Extended lymphadenectomy in colon cancer is crucial.

Authors:  Hermann Kessler; Werner Hohenberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

5.  The positive impact of surgical quality control on adequate lymph node harvest by standardized laparoscopic surgery and national quality assessment program in colorectal cancer.

Authors:  Daeyoun David Won; Sung Bong Choi; Yoon Suk Lee; Seong Taek Oh; Jun Gi Kim; In Kyu Lee
Journal:  Int J Colorectal Dis       Date:  2017-02-11       Impact factor: 2.571

Review 6.  Comparing the safety, efficacy, and oncological outcomes of laparoscopic and open colectomy in transverse colon cancer: a meta-analysis.

Authors:  Ioannis Baloyiannis; Konstantinos Perivoliotis; Panagiotis Ntellas; Katerina Dadouli; George Tzovaras
Journal:  Int J Colorectal Dis       Date:  2020-01-24       Impact factor: 2.571

7.  [Quality indicators for colon cancer surgery : Evidence-based development of a set of indicators for the outcome quality].

Authors:  J Hardt; H-J Buhr; C Klinger; S Benz; K Ludwig; J Kalff; S Post
Journal:  Chirurg       Date:  2018-01       Impact factor: 0.955

8.  Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: an analysis of 2,056 consecutive patients in two branches of same institution.

Authors:  Hong Hwa Chen; Dilip Chakravarty K; Jeng-Yi Wang; Chung-Rong Changchien; Reiping Tang
Journal:  Int J Colorectal Dis       Date:  2010-07-31       Impact factor: 2.571

9.  Total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer.

Authors:  Pramodh Chitral Chandrasinghe; Dileepa Senajith Ediriweera; Janaki Hewavisenthi; Sumudu Kumarage; Kemal Ismail Deen
Journal:  Indian J Gastroenterol       Date:  2013-09-19

10.  Lymph node ratio improves TNM and Astler-Coller's assessment of colorectal cancer prognosis: an analysis of 761 node positive cases.

Authors:  Renato Costi; Filippo Beggi; Valeria Reggiani; Matteo Riccò; Pellegrino Crafa; Melissa Bersanelli; Francesco Tartamella; Vincenzo Violi; Luigi Roncoroni; Leopoldo Sarli
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.